The Investment Firm Regulation and Directive (“IFR/IFD”) is the prudential regime for MiFID investment firms which aims to streamline and simplify the prudential requirements for EU investment firms. IFR/IFD applies to Hidden Road Partners CIV NL B.V. (“the “Firm” of “HRP NL”) as an AFM authorized and regulated firm.
The public disclosure requirements of IFR/IFD are set out in Part 6 of IFR. This disclosure is in respect of the accounting year ended 31 December 2023. HRP NL classifies as a Class 2 investment firm under IFR/IFD.
1.1. Business Summary
HRP NL is a subsidiary of Hidden Road, a global credit network for institutions enabling seamless access to traditional and digital markets. Conflict-free and built on a modern technology stack, Hidden Road removes complexity and cost in prime brokerage, clearing and financing. Hidden Road services a professional counterparty base made up of institutional investors, market makers, hedge funds and proprietary firms. The geographical location of potential counterparties will be global, focused where the market provides credit intermediation opportunities. HRP NL does not provide any services to retail clients.
The Firm is established to provide prime brokerage services in traditional and digital assets, from the Netherlands. To support this, the Firm is authorised and regulated as an investment firm by the Dutch Autoriteit Financiële Markten (“AFM”) with firm reference number 14006260 since 20 April 2023 for the following:
MiFID Service/Activity | Countries | Instruments |
A2 Execution of orders on behalf of clients | AT; BE; BG; HR; CY; CZ; DK; EE; FI; FR; DE; GR; HU; IS; IE; IT; LV; LI; LT; LU; MT; NL; NO; PL; PT; RO; SK; SI; ES; SE. | C1; C4; C5; C8; C10. |
A3 Dealing on own account |
Additionally, the Firm is registered as Crypto Service Provider with De Nederlandsche Bank (“DNB”) with firm reference number R188751 since 26 June 2023 for the following:
Wwft registration |
23a Custodian wallet providers |
23b Providers engaged in exchange services between virtual currencies and fiat currencies |
In 2023, HRP NL offered prime brokerage services to counterparties with respect to the following types of asset classes:
2.1. Overview of Governance Arrangements
2.1.1. The Board
For 2023, the Management Board of HRP NL existed of the following natural persons:
Strategic and operational decision-making responsibility at HRP NL ultimately rests with the Board. The Firm is headed by an effective Board, which meets formally on a calendar quarterly basis, and which directs and controls the Firm. The Board will also have the flexibility to hold ad hoc meetings, should the need arise to discuss matters of strategic importance on a more frequent basis. All such meetings will have written agendas and minutes to ensure a true record of events.
The Board comprises the above executive members and is privy to any information required to allow it to discharge its responsibilities. Management and financial information is distributed to senior managers and directors. The Board is supported by the local compliance and risk teams, who give updates at the quarterly board meetings.
HRP NL has a separate Risk and Compliance Committee and AML/CFT Committee. Additionally, HRP NL is part of the Hidden Road Group Coin Assessment Committee, Business Continuity Planning Committee and HRP Group Investment Committee.
2.1.2. Directorships
Neither of the directors have held office in executive or non-executive functions outside of the HRP Group throughout the financial year ending 31 December 2023.
2.1.3. Diversity
Due to the size of the Firm and the fact that the Firm has only just started operations, it is not proportionate for HRP NL to have a policy promoting diversity on the management body.
3.1. HRP NL’s approach to risk management
The Firm’s overall risk management objective is to develop internally a systems and controls framework to achieve the following:
The HRP Group abides by the following core list of Risk Management Principles:
The governing body takes an active role in the risk management process at HRP NL and is responsible for the maintenance of, and ultimately compliance with, the risk management strategy at the Firm. The Firm recognises that risk management processes are evolutionary and should be subject to ongoing review and modification.
HRP NL adopts a risk management framework, which integrates functions within the Firm and documents controls and policies that are proportionate to the size and complexity of the Firm.
There are also control and policy documents which form part of the risk management framework. These include but are not limited to:
3.2. Key risks and the associated risk management approach
The following section covers risk management objectives and policies for HRP NL’s relevant risks as set out in Parts Three, Four and Five of IFR. The firm is exposed to counterparty credit risk (K-TCD), operational risk (K-DTF), concentration risk (K-CON), market risk (K-NPR) and liquidity risk.
4.1. Composition of regulatory own funds
Template EU IF CC1.01 – Composition of regulatory own funds (Investment firms other than small and non-interconnected)
| (a) | (b) | |
Amounts {USD} | Source based on reference numbers/letters of the balance sheet in the audited financial statements | ||
Common Equity Tier 1 (CET1) capital: instruments and reserves | |||
1 | OWN FUNDS | 1,180,157 | |
2 | TIER 1 CAPITAL | 1,180,157 | |
3 | COMMON EQUITY TIER 1 CAPITAL | 1,180,157 | |
4 | Fully paid up capital instruments | 1 | Note 3 |
5 | Share premium | 1,499,999 | Note 4 |
6 | Retained earnings | -3,077 | Balance sheet retained earnings 2022 |
7 | Accumulated other comprehensive income | ||
8 | Other reserves | ||
9 | Minority interest given recognition in CET1 capital | ||
10 | Adjustments to CET1 due to prudential filters | ||
11 | Other funds | ||
12 | (-)TOTAL DEDUCTIONS FROM COMMON EQUITY TIER 1 | -316,766 | |
13 | (-) Own CET1 instruments | ||
14 | (-) Direct holdings of CET1 instruments | ||
15 | (-) Indirect holdings of CET1 instruments | ||
16 | (-) Synthetic holdings of CET1 instruments | ||
17 | (-) Losses for the current financial year | -311,766 | Total comprehensive income for the year |
18 | (-) Goodwill | ||
19 | (-) Other intangible assets | -5,000 | Note 2: stable-coins |
20 | (-) Deferred tax assets that rely on future profitability and do not arise from temporary differences net of associated tax liabilities | ||
21 | (-) Qualifying holding outside the financial sector which exceeds 15% of own funds | ||
22 | (-) Total qualifying holdings in undertaking other than financial sector entities which exceeds 60% of its own funds | ||
23 | (-) CET1 instruments of financial sector entites where the institution does not have a significant investment | ||
24 | (-) CET1 instruments of financial sector entities where the institution has a significant investment | ||
25 | (-)Defined benefit pension fund assets | ||
26 | (-) Other deductions | ||
27 | CET1: Other capital elements, deductions and adjustments | ||
28 | ADDITIONAL TIER 1 CAPITAL | ||
29 | Fully paid up, directly issued capital instruments | ||
30 | Share premium | ||
31 | (-) TOTAL DEDUCTIONS FROM ADDITIONAL TIER 1 | ||
32 | (-) Own AT1 instruments | ||
33 | (-) Direct holdings of AT1 instruments | ||
34 | (-) Indirect holdings of AT1 instruments | ||
35 | (-) Synthetic holdings of AT1 instruments | ||
36 | (-) AT1 instruments of financial sector entities where the institution does not have a significant investment | ||
37 | (-) AT1 instruments of financial sector entities where the institution has a significant investment | ||
38 | (-) Other deductions | ||
39 | Additional Tier 1: Other capital elements, deductions and adjustments | ||
40 | TIER 2 CAPITAL | ||
41 | Fully paid up, directly issued capital instruments | ||
42 | Share premium | ||
43 | (-) TOTAL DEDUCTIONS FROM TIER 2 | ||
44 | (-) Own T2 instruments | ||
45 | (-) Direct holdings of T2 instruments | ||
46 | (-) Indirect holdings of T2 instruments | ||
47 | (-) Synthetic holdings of T2 instruments | ||
48 | (-) T2 instruments of financial sector entities where the institution does not have a significant investment | ||
49 | (-) T2 instruments of financial sector entities where the institution has a significant investment | ||
50 | Tier 2: Other capital elements, deductions and adjustments |
4.2. Reconciliation to audited financial information
Template EU ICC2: Own funds: reconciliation of regulatory own funds to balance sheet in the audited financial statements
a Amount {USD} | b | c | ||
Balance sheet as in published/audited financial statements | Under regulatory scope of consolidation | Cross reference to EU IF CC1 | ||
As at period end | As at period end | |||
Assets | ||||
1 | Receivables from group companies | 8,480 | N/A | |
2 | Trade receivables | 2,292 | N/A | |
3 | Cash and cash equivalents | 1,649,593 | N/A | |
XXX | Total Assets | 1,660,365 | N/A | |
Liabilities | ||||
1 | Accounts payable | 198,582 | N/A | |
2 | Liabilities to group companies | 276,626 | N/A | |
XXX | Total Liabilities | 475,208 | N/A | |
Shareholders’ equity | ||||
1 | Called up share capital | 1 | N/A | 4 |
2 | Share premium | 1,499,999 | N/A | 5 |
3 | Retained earnings | -314,843 | N/A | 6; 17 |
XXX | Total Shareholders’ equity | 1,185,157 | N/A |
4.3. Main features of the firm’s own funds instruments
Table EU I CCA – Main features of own instruments issued by the firm.
a | ||
Qualitative or quantitative information – Free format | ||
1 | Issuer | Hidden Road Partners CIV NL B.V. |
2 | Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement) | N/A |
2a | Public or private placement | Private |
3 | Governing law(s) of the instrument | The Netherlands |
3a | Contractual recognition of write down and conversion powers of resolution authorities | N/A |
Regulatory treatment | ||
4 | Current treatment taking into account, where applicable, transitional CRR rules | CET1 |
5 | Post-transitional CRR rules | CET1 |
6 | Eligible at solo/(sub-)consolidated/ solo&(sub-)consolidated | Solo |
7 | Instrument type (types to be specified by each jurisdiction) | Equity |
8 | Amount recognised in regulatory capital or eligible liabilities (Currency in million, as of most recent reporting date) | 1 USD |
9 | Nominal amount of instrument | 1 USD |
EU-9a | Issue price | 1,500,000 USD |
EU-9b | Redemption price | N/A |
10 | Accounting classification | Equity |
11 | Original date of issuance | 24 June 2021 |
12 | Perpetual or dated | Perpetual |
13 | Original maturity date | N/A |
14 | Issuer call subject to prior supervisory approval | N/A |
15 | Optional call date, contingent call dates and redemption amount | N/A |
16 | Subsequent call dates, if applicable | N/A |
Coupons / dividends | ||
17 | Fixed or floating dividend/coupon | Floating dividend |
18 | Coupon rate and any related index | N/A |
19 | Existence of a dividend stopper | N/A |
EU-20a | Fully discretionary, partially discretionary or mandatory (in terms of timing) | N/A |
EU-20b | Fully discretionary, partially discretionary or mandatory (in terms of amount) | N/A |
21 | Existence of step up or other incentive to redeem | No |
22 | Noncumulative or cumulative | Noncumulative |
23 | Convertible or non-convertible | Non-convertible |
24 | If convertible, conversion trigger(s) | N/A |
25 | If convertible, fully or partially | N/A |
26 | If convertible, conversion rate | N/A |
27 | If convertible, mandatory or optional conversion | N/A |
28 | If convertible, specify instrument type convertible into | N/A |
29 | If convertible, specify issuer of instrument it converts into | N/A |
30 | Write-down features | N/A |
31 | If write-down, write-down trigger(s) | N/A |
32 | If write-down, full or partial | N/A |
33 | If write-down, permanent or temporary | N/A |
34 | If temporary write-down, description of write-up mechanism | N/A |
34a | Type of subordination (only for eligible liabilities) | N/A |
EU-34b | Ranking of the instrument in normal insolvency proceedings | Equity/last loss |
35 | Position in subordination hierarchy in liquidation (specify instrument type immediately senior to instrument) | Senior debt |
36 | Non-compliant transitioned features | N/A |
37 | If yes, specify non-compliant features | N/A |
37a | Link to the full term and conditions of the instrument (signposting) | N/A |
(1) Insert ‘N/A’ if the question is not applicable |
5.1. HRP NL own fund requirements
Investment firms shall at all times have own funds which amount to the highest of the following:
The results of these requirements for HRP NL are detailed in the table below:
Requirement | [$’S] |
Permanent Minimum Requirement: | 828,546 |
Fixed Overhead Requirement: | 312,500 |
Total K-Factor Requirement: | 3,621 |
RtC – SUM OF K-AUM, K-CMH, K-ASA AND K-COH | 0 |
RtM – SUM OF K-NPR AND K-CMG | 746 |
RtF – SUM OF K-TCD, K-DTF AND K-CON | 2,875 |
5.2. Adequacy of internal capital
IFR/IFD requires the Firm, at all times, to maintain overall financial resources, (both in capital and liquid assets), which are adequate, both in amount and quality to ensure that:
HRP NL assesses its compliance with IFR/IFD own funds and liquidity requirements through its Internal Capital and Liquidity Adequacy Assessment Process (“ICLAAP”). The ICLAAP is updated annually and on an event-driven basis.
When reviewing the ICLAAP, the Board satisfies themselves that the Firm has sufficient financial resources available to meet the own funds and liquidity requirements as at the date of review and on at least an annual forward-looking basis based on the Firm’s current business model and strategy.
ICLAAP and capital adequacy are a standing agenda item at HRP NL’s board meetings.
6.1. Qualitative Disclosure
HRP NL has in place a remuneration policy appropriate to the nature, scale and complexity of the risks and activities of the Firm. It is not proportionate or required for HRP NL to have a remuneration committee based on the criteria laid down in Article 32(4) of the IFD.
Material Risk Takers (“MRTs”) are identified through qualitative criteria based on their roles and responsibilities. This includes members of senior management and those responsible for managing a material risk within the Firm.
HRP NL offers fixed pay to all staff in an amount based on criteria such as the level of education, the degree of seniority, the level of expertise and skills required, the constraints and job experience and the relevant business sector.
All staff of HRP NL are also eligible to variable remuneration in the form of a discretionary cash bonus. The requirement for deferral of remuneration and the requirement to pay at least 50% in share-like instruments does not apply to HRP NL based on the criteria laid down in Article 32(4) of the IFD.
The value of the annual bonus awarded by HRP NL will be based on the performances of each relevant staff member, the business units that each staff member is part of and the global consolidated firm return on capital. The value of the bonus pool also has regard to HRP NL’s capital adequacy process. More specifically, the factors that will be assessed to determine the level of variable remuneration are:
These factors will be assessed across a number of years and the payment of this performance-based remuneration will take account of HRP NL’s business cycles and risks. HRP NL ensures that its remuneration policies are in line with its business strategy, objectives, values and long-term interests through a determined distribution policy for staff, management and shareholders which is aimed to reward each member while ensuring HRP’s financial stability, and bonuses are not paid from capital.
All variable remuneration will be subject to in-year adjustments, clawback and malus, where relevant and appropriate, for a minimum period of 3 years, for all MRTs. The specific circumstances under which clawback or malus will apply will rely on specific criteria and be determined on an individual basis but in all cases, HRP NL will be able to reduce an MRT’s variable remuneration by 100%. Generally, malus or clawback will apply where an MRT participated in, or was responsible for, conduct which resulted in significant losses to HRP NL and/or failed to meet appropriate standards of fitness and propriety. The effect of these provisions is to allow for sufficient time for risks to HRP NL to crystalise, and for subsequent adjustment to variable remuneration to be made.
It is not HRP NL’s policy to make severance payments to employees on early termination of their contract, however payment may be made for their statutory minimum notice period entitlements.
6.2. Quantitative Disclosures
Fixed remuneration ($) | Variable remuneration ($) | Total remuneration ($) | |
MRTs | 969,650 | 280,568 | 1,250,218 |
No MRTs received guaranteed variable remuneration. There were no severance payments to MRTs in the year ended 31 December 2023.